Lung Cancer International

Show Articles
Journal Properties
  • Number of Articles
    29
  • ISSN
    2090-3197
  • e-ISSN
    2090-3200
  • Publisher
    Hindawi Limited
  • Indian UGC
  • DOAJ (latest)
Description
Lung Cancer International is a peer-reviewed, open-access journal dedicated to advancing the understanding, prevention, diagnosis, and treatment of lung cancer. With a primary focus on translational and clinical research, the journal bridges the gap between laboratory findings and practical applications in patient care. Key areas of interest include biomarkers, novel therapies, surgical techniques, and innovative diagnostic imaging approaches. The journal covers a wide array of topics, from the molecular mechanisms driving lung cancer development to clinical trials evaluating new treatment modalities. It explores the role of early detection strategies, targeted therapies, immunotherapies, and the management of advanced-stage disease. Lung Cancer International welcomes submissions from researchers, clinicians, and other healthcare professionals involved in lung cancer research and patient care. Indexed in major databases, it provides a valuable platform for disseminating cutting-edge research to a global audience. By publishing high-quality original research, reviews, and case studies, Lung Cancer International aims to improve outcomes for individuals affected by lung cancer. Researchers are encouraged to submit their work, contributing to the growing body of knowledge that informs evidence-based practice and ultimately enhances patient well-being.